Eledon Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eledon Pharmaceuticals

11/08/2022 22:01

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 65 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 70 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Eledon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 65 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Eledon Pharmaceuticals Inc shares had risen by 38.9% this
quarter and lost 23.1% so far this year.
    * The company reported a quarterly loss of $9.25 million.
    * Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.70          -0.65          Beat
 Mar. 31 2022      -0.68          -0.69          Missed
 Dec. 31 2021      -0.75          -0.59          Beat
 Sep. 30 2021      -0.65          -0.66          Missed